Willin/FRMD6 Mediates Mitochondrial Dysfunction Relevant to Neuronal Aβ Toxicity.

Area of Science:

• Neuroscience
• Genetics
• Cell Biology

Background:

• Willin/FRMD6 is a potential Alzheimer's disease (AD) risk gene.
• Mechanisms linking Willin/FRMD6 to AD pathogenesis are not fully understood.

Purpose of the Study:

• Investigate the direct effects of amyloid-beta (Aβ) on Willin/FRMD6 expression.
• Elucidate the role of mitochondrial oxidative stress in Willin/FRMD6's function in AD.

Main Methods:

• Utilized mouse hippocampal HT-22 cells and primary mouse neurons.
• Assessed Willin/FRMD6 protein expression levels.
• Examined mitochondrial morphology, function, and energetics.
• Analyzed ERK1/2 signaling pathway activation.

Main Results:

• Aβ exposure led to decreased Willin/FRMD6 protein levels.
• Willin/FRMD6 knockdown resulted in mitochondrial dysfunction and fragmentation.
• Knockdown also caused upregulation of ERK1/2 signaling.
• Increased Willin/FRMD6 expression ameliorated Aβ-induced mitochondrial abnormalities.

Conclusions:

• Mitochondrial oxidative stress is a potential mechanism for Willin/FRMD6's role in AD.
• Enhancing Willin/FRMD6 expression may offer a therapeutic approach for AD by protecting against mitochondrial and neuronal dysfunction.